A detailed history of Ameriprise Financial Inc transactions in Albemarle Corp stock. As of the latest transaction made, Ameriprise Financial Inc holds 1,241,800 shares of ALB stock, worth $112 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,241,800
Previous 1,129,558 9.94%
Holding current value
$112 Million
Previous $108 Million 9.0%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.85 - $100.09 $8.18 Million - $11.2 Million
112,242 Added 9.94%
1,241,800 $118 Million
Q2 2024

Aug 14, 2024

BUY
$92.77 - $135.46 $20.6 Million - $30.1 Million
222,366 Added 24.51%
1,129,558 $108 Million
Q1 2024

May 15, 2024

BUY
$108.73 - $146.89 $53.9 Million - $72.8 Million
495,686 Added 120.46%
907,192 $120 Million
Q4 2023

Feb 14, 2024

SELL
$113.26 - $170.8 $148,936 - $224,602
-1,315 Reduced 0.32%
411,506 $59.5 Million
Q3 2023

Nov 14, 2023

BUY
$162.63 - $243.44 $5.47 Million - $8.19 Million
33,662 Added 8.88%
412,821 $70.2 Million
Q2 2023

Aug 14, 2023

BUY
$172.91 - $232.22 $109,106 - $146,530
631 Added 0.17%
379,159 $84.6 Million
Q1 2023

May 15, 2023

SELL
$208.49 - $290.15 $10.6 Million - $14.8 Million
-50,953 Reduced 11.86%
378,528 $83.7 Million
Q4 2022

Feb 14, 2023

SELL
$214.02 - $325.38 $56.7 Million - $86.3 Million
-265,118 Reduced 38.17%
429,481 $93.1 Million
Q3 2022

Nov 14, 2022

SELL
$195.82 - $307.05 $67.2 Million - $105 Million
-343,426 Reduced 33.08%
694,599 $184 Million
Q2 2022

Aug 15, 2022

SELL
$187.76 - $270.92 $9.7 Million - $14 Million
-51,670 Reduced 4.74%
1,038,025 $217 Million
Q1 2022

May 16, 2022

SELL
$172.09 - $246.0 $10.2 Million - $14.6 Million
-59,310 Reduced 5.16%
1,089,695 $241 Million
Q4 2021

Feb 14, 2022

SELL
$214.16 - $283.8 $9.07 Million - $12 Million
-42,374 Reduced 3.56%
1,149,005 $268 Million
Q3 2021

Nov 15, 2021

SELL
$167.91 - $244.03 $6.11 Million - $8.88 Million
-36,401 Reduced 2.96%
1,191,379 $261 Million
Q2 2021

Aug 16, 2021

BUY
$143.7 - $176.01 $48.2 Million - $59 Million
335,353 Added 37.58%
1,227,780 $207 Million
Q1 2021

May 17, 2021

BUY
$140.69 - $185.25 $79.5 Million - $105 Million
564,884 Added 172.46%
892,427 $131 Million
Q4 2020

Feb 12, 2021

SELL
$86.73 - $149.91 $6.55 Million - $11.3 Million
-75,483 Reduced 18.73%
327,543 $48.3 Million
Q3 2020

Nov 16, 2020

SELL
$75.75 - $100.45 $3.48 Million - $4.61 Million
-45,943 Reduced 10.23%
403,026 $36 Million
Q2 2020

Aug 14, 2020

SELL
$52.7 - $86.74 $8.33 Million - $13.7 Million
-158,078 Reduced 26.04%
448,969 $34.7 Million
Q1 2020

May 15, 2020

SELL
$50.9 - $94.31 $2.52 Million - $4.67 Million
-49,472 Reduced 7.54%
607,047 $34.2 Million
Q4 2019

Feb 14, 2020

SELL
$60.74 - $73.04 $86.4 Million - $104 Million
-1,422,382 Reduced 68.42%
656,519 $48 Million
Q3 2019

Nov 14, 2019

SELL
$59.3 - $75.53 $1.63 Million - $2.08 Million
-27,534 Reduced 1.31%
2,078,901 $145 Million
Q2 2019

Aug 14, 2019

BUY
$63.3 - $86.94 $52.5 Million - $72.1 Million
829,282 Added 64.93%
2,106,435 $148 Million
Q1 2019

May 15, 2019

BUY
$72.69 - $92.28 $67.1 Million - $85.2 Million
923,737 Added 261.37%
1,277,153 $105 Million
Q4 2018

Feb 14, 2019

BUY
$73.13 - $107.99 $2.55 Million - $3.77 Million
34,869 Added 10.95%
353,416 $27.2 Million
Q3 2018

Nov 14, 2018

BUY
$90.9 - $106.6 $7.18 Million - $8.42 Million
79,026 Added 32.99%
318,547 $32 Million
Q2 2018

Aug 14, 2018

BUY
$88.96 - $104.92 $9.12 Million - $10.8 Million
102,546 Added 74.86%
239,521 $22.6 Million
Q1 2018

May 15, 2018

SELL
$89.56 - $137.45 $1.09 Million - $1.67 Million
-12,148 Reduced 8.15%
136,975 $12.7 Million
Q4 2017

Feb 12, 2018

SELL
$127.48 - $144.58 $17.3 Million - $19.7 Million
-135,977 Reduced 47.69%
149,123 $19.1 Million
Q3 2017

Nov 07, 2017

BUY
$109.36 - $136.31 $31.2 Million - $38.9 Million
285,100
285,100 $39 Million

Others Institutions Holding ALB

About ALBEMARLE CORP


  • Ticker ALB
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 117,129,000
  • Market Cap $10.5B
  • Description
  • Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...
More about ALB
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.